NOS3 and autoimmune polyendocrinopathy: APS patients exhibit reduced nitric oxide (NO) serum levels and impaired endothelial vascular response [15,16], both referred to as a reduced NO production due to suppression of endothelial nitric oxide synthase (eNOS) activity [13,14].